Eiger BioPharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
EIGRQ on OTC
Location
2155 Park Boulevard, Palo Alto, CA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Eiger BioPharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Kayne 10%+ Owner $1.6M Oct 31, 2023
Leen Kawas 10%+ Owner $1.31M Oct 31, 2023
Jeffrey S. Glenn Director $101K Mar 1, 2023
David A. Cory President and CEO, Director $50.4K Mar 11, 2022
Thomas Dietz Director $21.1K Mar 1, 2023
Eldon C. Mayer III Ex VP & Chief Commerc. Officer $16.7K Mar 17, 2023
Sriram Ryali Chief Financial Officer $12.4K Mar 14, 2022
Ingrid Choong Chief Business Officer $9.97K Aug 31, 2023
Amit Sachdev Director $4.76K Mar 1, 2023
Evan Loh Director $4.17K Mar 1, 2023
David Apelian CEO, Director $3.28K Jul 3, 2023
Christine Murray Director $3.28K Mar 1, 2023
Erik Atkisson GC & Chief Compliance Officer $1.79K Jan 26, 2023
Kim Sablich Director $1.79K Mar 1, 2023
Lisa Kelly-Croswell Director Mar 1, 2023
William G. Kachioff Cfo Apr 12, 2023
James Vollins General Counsel Apr 30, 2023

Recent Insider Transactions by Companies or Individuals for Eiger BioPharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.